Do we need autologous blood donation?;Faut-il encore faire des transfusions autologues différées programmées?

Annales Francaises d'Anesthesie et de Reanimation

Volumn 23, Issue 5, 2004, Pages 468-473

  Schved, J F ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

H movigilance; Preoperative autologous blood donation; S curit transfusionnelle; Transfusion; Transfusion autologue programm e

Indexed keywords

BACTERIUM CONTAMINATION; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD GROUP ABO SYSTEM; DISEASE TRANSMISSION; EVALUATION; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION RISK; MATHEMATICAL MODEL; PREOPERATIVE CARE; REVIEW; VIRUS INFECTION; YERSINIA ENTEROCOLITICA;

EID: 2542474239     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2004.01.009     Document Type: Short Survey

References (28)

1. Toy P.T., Strauss R.G., Stehling L.C., Sears R., Price T.H., Rossi E.C., et al. Predeposited autologous blood for elective surgery. A national multicenter study. N Engl J Med. 316:1987;517-520
2. Duguid J.K. Autologous blood transfusion. Clin Lab Haematol. 21:1999;371-376
3. Finucane M.L., Slovic P., Mertz C.K. Public perception of the risk of blood transfusion. Transfusion. 40:2000;1017-1022
4. Pillonel J., Laperche S., Barlet V., Coste J., Levayer T., Renaudier P., Soler C. the study group " Transfusion Transmissible Agents Group". Risk of Transfusion-Transmitted Viral Infections (HIV, HCV and HBV) and impact of NAT implementation in France. 2002;Congrès ISBT, Paris
5. Goodnough L.T., Brecher M.E., Kanter M.H., Aubuchon J.P. Transfusion medicine. First of two parts: blood transfusion. N Engl J Med. 340:1999;438-447
6. Goodnough L.T., Brecher M.E., Kanter M.H., Aubuchon J.P. Transfusion medicine. Second of two parts: blood conservation. N Engl J Med. 340:1999;525-533
7. Rosencher N., Kerkkamp H.E.M., Macheras G., Munuera L.M., Menichella G., Barton D.M., et al. Orthopedic surgery transfusion hemoglobin european overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 43:2003;459-469
8. Bierbaum B.E., Hill C., Callaghan J., Galante J.O., Rubash H.E., Tooms R.E., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg. Am. 81:1999;2-10
9. Forgie M.A., Wells P.S., Laupacis A., Fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med. 158:1998;610-616
10. Graham I.D., Fergusson D., Dokainish H., Biggs J., McAuley L., Laupacis A. Autologous versus allogeneic transfusion: patients' perceptions and experiences. CMAJ. 160:1999;989-995
11. Goodnough L.T. Controversies in autologous blood procurement. Br J Anaesth. 81:(Suppl 1):1998;67-72
12. Ortolano G.A., Russel R., Capetandes A., Wenz B. Transfusion-associated immunosuppression-Heuristic model or clinical concern. Mod Asp Immunobiol. 2:2002;159-165
13. Busch O.R., Hop W.C., Hoynck van Papendrecht M.A., Marquet R.L., Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med. 328:1993;1372-1376
14. Dupuis J.Y., Bart B., Bryson G., Robblee J. Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery. CMAJ. 160:1999;997-1002
15. Kanter M.H., van Maanen D., Anders K.H., Castro F., Mya W.W., Clark K. Preoperative autologous blood donations before elective hysterectomy. JAMA. 276:1996;798-801
16. Goodnough L.T., Brecher M.E. Autologous blood transfusion. Intern Med. 37:1998;238-245
17. Brecher M.E., Goodnough L.T. The rise and fall of preoperative autologous blood donation. Transfusion. 41:2001;1459-1462
18. Cohen J.A., Brecher M.E. Preoperative autologous blood donation: benefit or detriment? A mathematical analysis. Transfusion. 35:1995;640-644
19. Gould S.A., Forbes J.M. Controversies in transfusion medicine: indications for autologous and allogeneic transfusion should be the same: pro. Transfusion. 35:1995;446-449
20. Miller R.D., von Ehrenburg W. Controversies in transfusion medicine: indications for autologous and allogeneic transfusion should be the same: con. Transfusion. 35:1995;450-452
21. Billote D.B., Glisson S.N., Green D., Wixson R.L. A prospective randomised study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg. 84:2002;1299-1304
22. Blumberg N., Kirkley S.A., Heal J.M. A cost analysis of autologous and allogeneic transfusions in replacement surgery. Am J Surg. 171:1996;324-330
23. Etchason J., Petz L., Keeler E., Calhoun L., Kleinman S., Snider C., et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med. 332:1995;719-724
24. Tretiak R., Laupacis A., Riviere M., McKerracher K., Souetre E. Canadian Cost of Transfusion Study Group. Cost of allogeneic and autologous blood transfusion in Canada. CMAJ. 154:1996;1501-1508
25. Popovsky M.A., Whitaker B., Arnold N.L. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion. 35:1995;734-737
26. Sonnenberg F.A., Gregory P., Yomtovian R., Russell L.B., Tierney W., Kosmin M., et al. The cost-effectiveness of autologous transfusion revisited: implications of an increased risk of bacterial infection with allogeneic transfusion. Transfusion. 39:1999;384-387
27. Kasper S.M., Ellering J., Stachwitz P., Lynch J., Grunenberg R., Buzello W. All adverse events in autologous blood donors with cardiac disease are not necessarily caused by blood donation. Transfusion. 38:1998;669-673
28. Levi J.H., Morales A., Lemmer J.H. Pharmacological approaches to prevent or decrease bleeding in surgical patients. Spiess B.D., Count R.B., Gould S.A. Perioperative transfusion medicine. 1998;147-156 Williams and Wilkins, Baltimore, MD